Currently, the only long-acting HIV treatment available in the US is Viiv Healthcare’s Cabenuva, which is administered as a ...

Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...

GILD and partner MRK advance novel investigational combination regimen, a weekly oral HIV treatment, to phase III.

It is also eyeing £2 billion plus in sales for HIV pre-exposure prophylaxis (PrEP) drug Cabenuva (cabotegravir), hepatitis B virus (HBV) antisense drug GSK3228836, and Zejula (niraparib), the ...

Patients with HIV who receive Cabenuva injections are more closely followed by physicians to assess the risk of cardiovascular, liver and kidney disease. The more frequent interactions with healthcare ...

The 1) Market is expected to reach a substantial USD 34.83 billion by 2033, according to a new report. This reflects a ...

The list includes dengue fever, chikungunya, leptospirosis and Valley fever, says University of Washington professor Peter ...